Recurrent lymphoid and myeloid relapses due to treatment cessations reveal natural history of Ph-positive B-ALL and pose a diagnostic challenge
Am J Hematol
.
2024 Apr;99(4):721-726.
doi: 10.1002/ajh.27210.
Epub 2024 Jan 19.
Authors
Shimin Hu
1
,
Elias J Jabbour
2
,
Collin Y Hu
1
,
Guilin Tang
1
,
Wei Wang
1
,
L Jeffrey Medeiros
1
,
Carlos Bueso-Ramos
1
Affiliations
1
Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
2
Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
PMID:
38240333
DOI:
10.1002/ajh.27210
No abstract available
Publication types
Case Reports
MeSH terms
Chronic Disease
Humans
Leukemia, Myelogenous, Chronic, BCR-ABL Positive*
Neoplasm Recurrence, Local*
Withholding Treatment